Antiviral activities of silver sulfadiazine in ocular infection.
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D002460:Cell Line; D003315:Cornea / Q000473:pathology; D006224:Cricetinae; D004247:DNA / Q000037:antagonists & inhibitors; D005128:Eye Diseases / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007635:Keratitis, Dendritic / Q000188:drug therapy*; D007668:Kidney; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa; D011817:Rabbits; D012834:Silver / Q000494:pharmacology / Q000627:therapeutic use*; D018139:Simplexvirus / Q000187:drug effects; D013411:Sulfadiazine / Q000494:pharmacology / Q000627:therapeutic use*; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014721:Vesicular stomatitis Indiana virus / Q000187:drug effects; D014777:Virus Diseases / Q000188:drug therapy* / Q000473:pathology; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D013411:Sulfadiazine; D014316:Tritium; D012834:Silver; D004247:DNA; D013936:Thymidine